A detailed history of Caption Management, LLC transactions in Arvinas, Inc. stock. As of the latest transaction made, Caption Management, LLC holds 527,300 shares of ARVN stock, worth $9.32 Million. This represents 0.1% of its overall portfolio holdings.

Number of Shares
527,300
Previous 44,200 1092.99%
Holding current value
$9.32 Million
Previous $1.09 Million 829.04%
% of portfolio
0.1%
Previous 0.02%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 14, 2025

BUY
$17.83 - $28.04 $3.69 Million - $5.8 Million
206,915 New
206,915 $3.97 Million
Q1 2022

May 13, 2022

BUY
$60.27 - $81.57 $174,783 - $236,552
2,900 Added 2900.0%
3,000 $202,000
Q4 2020

Feb 16, 2021

SELL
$20.19 - $84.93 $644,061 - $2.71 Million
-31,900 Reduced 99.69%
100 $8,000
Q3 2020

Nov 16, 2020

BUY
$22.99 - $36.34 $735,680 - $1.16 Million
32,000 New
32,000 $755,000

Others Institutions Holding ARVN

About ARVINAS, INC.


  • Ticker ARVN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 53,205,300
  • Market Cap $940M
  • Description
  • Arvinas, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of therapies to degrade disease-causing proteins. Its lead product candidates include Bavdegalutamide, a proteolysis targeting chimera (PROTAC) protein degrader that is in phase I clinical trial targeting the androgen receptor ...
More about ARVN
Track This Portfolio

Track Caption Management, LLC Portfolio

Follow Caption Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Caption Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Caption Management, LLC with notifications on news.